The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04546009
Brief Title: A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)

First Submitted : September 8, 2020
First Submitted that Met QC Criteria : September 8, 2020
First Posted : September 11, 2020

Last Update Submitted that Met QC Criteria : May 7, 2024
Last Update Posted : May 8, 2024